Smits et al. used midbrain-specific organoids generated from PD patients carrying the LRRK2-G2019S mutation and demonstrated a reduction in the function and number of DA neurons in LRRK2-G2019S compared to the control organoids [29]. The gene discussed is LRRK2; the disease is Parkinson disease.